Stay updated on Secukinumab in Psoriatic Arthritis: Clinical Trial
Sign up to get notified when there's something new on the Secukinumab in Psoriatic Arthritis: Clinical Trial page.

Latest updates to the Secukinumab in Psoriatic Arthritis: Clinical Trial page
- Check2 days agoChange DetectedA site-wide banner announces an NIH website transition and says both “Artificial Intelligence” and “Super Intelligence” may appear in NIH content during the transition.SummaryDifference1%

- Check9 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the error page.SummaryDifference0.2%

- Check16 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the usual study details with a basic error screen to indicate restricted access.SummaryDifference18%

- Check58 days agoChange DetectedAdded NIH grant/contract note to the study identifiers. The page revision was updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page’s revision tag was updated to Revision: v3.6.5, replacing the previous v3.6.4, indicating a new version of the page content.SummaryDifference0.0%

Stay in the know with updates to Secukinumab in Psoriatic Arthritis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Secukinumab in Psoriatic Arthritis: Clinical Trial page.